Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06721273
NA

Iodine Supplementation and Fertility Parameters

Sponsor: Tehran University of Medical Sciences

View on ClinicalTrials.gov

Summary

Iodine has been identified as a potential factor influencing female fertility during the childbearing years. The American Thyroid Association recommends that women attempting to conceive take a supplement containing 150 µg of iodine. However, no clinical trials have specifically examined the necessity of iodine supplementation in women experiencing infertility. Furthermore, no information is available on the optimal dose and duration of iodine supplementation to increase the chances of successful treatment in this group of women. Therefore, this study aims to investigate the effects of iodine supplementation on fertility parameters in infertile women.

Official title: The Effect of Iodine Supplementation on Fertility Parameters in Women Experiencing Infertility

Key Details

Gender

FEMALE

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

230

Start Date

2025-03-01

Completion Date

2027-03-01

Last Updated

2024-12-06

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Iodine

In intervention group women will take 150 µg daily (one tablet per day, Tavan Institute, Tehran, Iran) that will be 2 months before starting the new in vitro fertilization (IVF) cycle.

DIETARY_SUPPLEMENT

Placebo

Women will take a placebo tablet daily (containing white wheat flour, which is similar to iodine table in terms of size, shape, and color, Tavan Institute, Tehran, Iran) 2 months before starting the new IVF cycle.